Leo Pharma
Clinical trials sponsored by Leo Pharma, explained in plain language.
-
New study tracks Real-World relief for stubborn hand eczema
Disease control ENROLLING_BY_INVITATIONThis study follows 1000 adults with moderate to severe chronic hand eczema who are prescribed delgocitinib cream by their doctor. Researchers will track changes in skin symptoms and any side effects over 52 weeks to see how well the cream works in real-life settings. The goal is …
Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
LEO Pharma's new drug study pulled before any volunteers enrolled
Knowledge-focused TerminatedThis was an early-stage study designed to check the safety and tolerability of a new drug called LEO 142397 in healthy people. The study was planned in two parts: one group would get a single dose, and another would take it daily for two weeks. However, the study was withdrawn be…
Phase: PHASE1 • Sponsor: LEO Pharma • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:03 UTC